These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6760644)

  • 21. Camptothecins: from bench research to hospital wards.
    Potmesil M
    Cancer Res; 1994 Mar; 54(6):1431-9. PubMed ID: 8137244
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
    Salmon SE; Hamburger AW; Soehnlen B; Durie BG; Alberts DS; Moon TE
    N Engl J Med; 1978 Jun; 298(24):1321-7. PubMed ID: 77475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of anticancer drugs with the human tumor stem cell assay.
    Salmon SE; Von Hoff DD
    Semin Oncol; 1981 Dec; 8(4):377-85. PubMed ID: 6275552
    [No Abstract]   [Full Text] [Related]  

  • 24. New strategies in cancer chemotherapy.
    Bonadonna G
    Cell Biophys; 1986 Dec; 9(1-2):243-56. PubMed ID: 2436797
    [No Abstract]   [Full Text] [Related]  

  • 25. Human tumor stem-cell assay.
    N Engl J Med; 1983 Jun; 308(24):1478-81. PubMed ID: 6855820
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical significance of so-called oncobiograms for chemotherapy of tumors].
    Mattern J; Wayss K; Volm M
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1683-8. PubMed ID: 6754324
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer chemotherapy using a clonogenic cell assay.
    Strayer DR; Kahn SB
    Am Fam Physician; 1983 Apr; 27(4):223-5. PubMed ID: 6837405
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical aspects of drug resistance.
    Holland JF
    Antibiot Chemother (1971); 1978; 23():238-46. PubMed ID: 348082
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolution of cancer chemotherapy.
    Chabner BA
    Hosp Pract (Off Ed); 1985 Apr; 20(4):115-9, 123-7. PubMed ID: 3932415
    [No Abstract]   [Full Text] [Related]  

  • 30. New anticancer drugs.
    Recent Results Cancer Res; 1980; 70():1-229. PubMed ID: 6986640
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination chemotherapy--theory and practice.
    Capizzi RL; Keiser LW; Sartorelli AC
    Semin Oncol; 1977 Jun; 4(2):227-53. PubMed ID: 327555
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clonogenic cultures of human tumours. Experience and prospects in cancer chemotherapy (author's transl)].
    Rozencweig M; Makaroff O; Prevost JM; Kenis Y; Klastersky J
    Nouv Presse Med; 1982 Mar; 11(14):1071-4. PubMed ID: 7079123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present status of chemosensitivity assays.
    Kern DH; Bertelsen CA
    Int Adv Surg Oncol; 1984; 7():187-213. PubMed ID: 6469373
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques.
    Connors TA; Phillips BJ
    Biochem Pharmacol; 1975 Dec; 24(24):2217-24. PubMed ID: 1218096
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problem of screening of antineoplastic drugs in tissue and cell cultures].
    Dobrynin IaV
    Eksp Onkol; 1985; 7(2):9-15. PubMed ID: 4006851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenografts.
    Taetle R; Howell SB; Giuliani FC; Koziol J; Koessler A
    Cancer; 1982 Oct; 50(8):1455-61. PubMed ID: 6956427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of chemotherapeutic agents.
    Hamburger AW
    Cancer Invest; 1991; 9(6):683-90. PubMed ID: 1747794
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary on "clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy.
    Martin DS; Stolfi RL; Sawyer RC
    Cancer Treat Rep; 1984 Nov; 68(11):1317-8. PubMed ID: 6498852
    [No Abstract]   [Full Text] [Related]  

  • 39. Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32.
    Blum RH; Garnick MB; Israel M; Panellos GP; Henderson IC; Frei E
    Recent Results Cancer Res; 1981; 76():7-15. PubMed ID: 7232854
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental models and their clinical correlations.
    Carter SK; Goldin A
    Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.